Skip to content

The success of a new dental implant in the jaw bone

Clinical and radiological success of a novel dental implant with transmucosal implantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN15663606
Enrollment
80
Registered
2022-08-20
Start date
2022-08-25
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Single or multiple teeth missing in both jaws Oral Health

Interventions

Replacement of missing teeth with tissue level implants (TLX) and recording of clinical data at every follow-up visit. There will be no randomization.

Sponsors

Straumann (Switzerland)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years old and over 2. Requiring a single or partial fixed implant prosthesis (FDP) of maxillary and mandibular arch 3. Otherwise healthy patients 4. Full mouth bleeding and full mouth plaque index lower than or equal to 25% 5. Bone height for at least 4 mm-long implants 6. Bone width of at least 3 mm and 4 mm 7. Fresh extraction sockets with an intact buccal wall

Exclusion criteria

Exclusion criteria: 1. Psychiatric contraindications 2. Pregnancy or nursing 3. Any interfering medication such as: 3.1. Steroid therapy 3.2. Bisphosphonate therapy 4. Alcohol or drug abuse 5. Heavy smoking (>10 cigarettes/day) 6. Radiation therapy to head or neck region within 5 years 7. Untreated periodontitis 8. Acute and chronic infections of the adjacent tissues or natural dentition 9. Severe maxillomandibular skeletal discrepancy 10. High and moderate parafunctional activity 11. Absence of opposite teeth

Design outcomes

Primary

MeasureTime frame
1. Implantation survival rate (ISR) measured during a control visit every 4 months. A surviving implant is an implant that maintains its function in the mouth. 2. Marginal bone loss (MBL) measured using annual periapical X-rays

Secondary

MeasureTime frame
1. Initial implant stability quotient values (ISQ-0) and insertion torque at implant placement recorded at each scheduled visit every 4 months from implant placement 2. Peri-implant soft tissue parameters recorded at each scheduled visit every 4 months from implant placement: 2.1. Bleeding on probing (BoP) measured using a periodontal probe 2.2. Probing depth (PD) measured using a periodontal probe 2.3. Implant stability measured using ISQ values from a resonance frequencies analysis using the Osstel device

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026